Vertigo, characterized by a sensation of feeling off balance, is a symptom that can be indicative of various underlying conditions. It is often associated with a feeling of spinning dizziness. This article aims to provide a comprehensive clinical approach to vertigo, enabling healthcare professionals to accurately diagnose and effectively treat this common yet complex symptom.
The key to differentiating vertigo from other forms of dizziness lies in the patient's description of the symptom. Vertigo is typically described as a sensation of the environment spinning around them or a feeling of motion when stationary. It may be accompanied by nausea, vomiting, nystagmus, or balance problems.
Vertigo can be a symptom of both peripheral and central causes. Peripheral causes include benign paroxysmal positional vertigo (BPPV), Meniere's disease, and vestibular neuritis, among others. Central causes include migraines, multiple sclerosis, and cerebrovascular disease. A thorough history and physical examination, including a neurological and otoscopic examination, are vital in diagnosing the cause of vertigo. Further diagnostic tools such as vestibular testing and imaging may be required in some cases.
Treatment of vertigo is based on the underlying cause. BPPV may be treated with canalith repositioning maneuvers, while Meniere's disease may require dietary modifications and diuretics. Vestibular rehabilitation therapy can be beneficial for patients with chronic symptoms. In some cases, surgery may be indicated. It is also essential to manage any associated symptoms such as nausea and anxiety.
Vertigo is a symptom that requires a comprehensive and systematic approach for accurate diagnosis and effective management. By understanding the various causes and appropriate diagnostic tools, healthcare professionals can ensure that patients receive the most suitable treatment for their condition, improving their quality of life and reducing the risk of complications.
1.
A study on lung cancer provides additional proof of the value of screening.
2.
Enzalutamide vs Abiraterone: Which is Better for mCSPC?
3.
Is It Really Cancer? More Concerns About Accelerated Approval; Metformin and Cancer
4.
Germline Profiling May Improve Risk Stratification in t-MNs
5.
If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version
1.
Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options
2.
Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide
3.
Case Study: Revolutionizing PNH Treatment with Eculizumab for Superior Patient Outcomes
4.
Practical Developments in Hematology in the Digital Era
5.
Advanced Pathways in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part XI
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
5.
Efficient Management of First line ALK-rearranged NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation